Alexa Gillman

2.9k total citations
9 papers, 90 citations indexed

About

Alexa Gillman is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Alexa Gillman has authored 9 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Public Health, Environmental and Occupational Health and 2 papers in Cancer Research. Recurrent topics in Alexa Gillman's work include Retinal and Optic Conditions (1 paper), Ethics in Clinical Research (1 paper) and Biomedical Ethics and Regulation (1 paper). Alexa Gillman is often cited by papers focused on Retinal and Optic Conditions (1 paper), Ethics in Clinical Research (1 paper) and Biomedical Ethics and Regulation (1 paper). Alexa Gillman collaborates with scholars based in United Kingdom and United States. Alexa Gillman's co-authors include Judith M. Bliss, James Wason, Ruwanthi Kolamunnage‐Dona, Alison McDonald, Charlotte Rawcliffe, Wendy Wood, Tim Sprosen, Jill Knox, Marian Duggan and James Paul and has published in prestigious journals such as Cancer Research, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Alexa Gillman

9 papers receiving 89 citations

Peers

Alexa Gillman
Aneta Suder United Kingdom
Archie Macnair United Kingdom
Harkiran Sagoo United Kingdom
Marla Daves United States
Artur Nowak United States
Silviya Balabanova United Kingdom
Katherine M Soltys United States
Katherine Murphy United States
M. Lewicka Poland
Aneta Suder United Kingdom
Alexa Gillman
Citations per year, relative to Alexa Gillman Alexa Gillman (= 1×) peers Aneta Suder

Countries citing papers authored by Alexa Gillman

Since Specialization
Citations

This map shows the geographic impact of Alexa Gillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa Gillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa Gillman more than expected).

Fields of papers citing papers by Alexa Gillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexa Gillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa Gillman. The network helps show where Alexa Gillman may publish in the future.

Co-authorship network of co-authors of Alexa Gillman

This figure shows the co-authorship network connecting the top 25 collaborators of Alexa Gillman. A scholar is included among the top collaborators of Alexa Gillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexa Gillman. Alexa Gillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Philipps, L., Stephanie L. Foster, Jacqui Gath, et al.. (2023). Study within a trial of electronic versus paper-based Patient-Reported oUtcomes CollEction (SPRUCE): study protocol for a partially randomised patient preference study. BMJ Open. 13(9). e073817–e073817. 1 indexed citations
2.
Kolamunnage‐Dona, Ruwanthi, et al.. (2019). Biomarker-guided trials: Challenges in practice. Contemporary Clinical Trials Communications. 16. 100493–100493. 30 indexed citations
3.
Duley, Lelia, Alexa Gillman, Marian Duggan, et al.. (2018). What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK. Trials. 19(1). 15–15. 36 indexed citations
4.
Bliss, Judith M., James P. Morden, Abigail Evans, et al.. (2017). Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker. Cancer Research. 77(4_Supplement). P2–5. 3 indexed citations
5.
Lorente, David, Praful Ravi, Alexa Gillman, et al.. (2015). 2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). European Journal of Cancer. 51. S504–S504. 1 indexed citations
6.
Lewis, Rebecca, Charlotte Friend, Stephanie Burnett, et al.. (2015). Design considerations when transitioning from paper case report forms (CRFS) to electronic data capture (EDC). Trials. 16(S2). 2 indexed citations
7.
Burnett, Stephanie, James P. Morden, Alexa Gillman, et al.. (2015). Benefits and challenges of electronic data capture (EDC) systems versus paper case report forms. Trials. 16(S2). 5 indexed citations
8.
Mateo, Joaquı́n, Emma Hall, Shahneen Sandhu, et al.. (2014). Antitumour Activity of the Parp Inhibitor Olaparib in Unselected Sporadic Castration-Resistant Prostate Cancer (Crpc) in the Toparp Trial. Annals of Oncology. 25. v1–v1. 10 indexed citations
9.
Gillman, Alexa. (1965). PATHOGENESIS OF COMPLICATIONS FOLLOWING CATARACT SURGERY. International Ophthalmology Clinics. 5(1). 207–256. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026